3/27
09:53 am
immx
Immix Biopharma (IMMX) had its "market outperform" rating reaffirmed by Citizens Jmp. They now have a $23.00 price target on the stock.
Medium
Report
Immix Biopharma (IMMX) had its "market outperform" rating reaffirmed by Citizens Jmp. They now have a $23.00 price target on the stock.
3/27
08:02 am
immx
Immix Biopharma (IMMX) had its price target raised by HC Wainwright from $12.00 to $15.00. They now have a "buy" rating on the stock.
Medium
Report
Immix Biopharma (IMMX) had its price target raised by HC Wainwright from $12.00 to $15.00. They now have a "buy" rating on the stock.
3/25
08:42 am
immx
Immix Biopharma (IMMX) is now covered by Morgan Stanley. They set an "overweight" rating and a $20.00 price target on the stock.
Low
Report
Immix Biopharma (IMMX) is now covered by Morgan Stanley. They set an "overweight" rating and a $20.00 price target on the stock.
3/15
01:05 am
immx
Medium
Report
3/9
08:03 am
immx
Immix Biopharma (IMMX) is now covered by Citizens Jmp. They set a "market outperform" rating and a $23.00 price target on the stock.
High
Report
Immix Biopharma (IMMX) is now covered by Citizens Jmp. They set a "market outperform" rating and a $23.00 price target on the stock.
3/7
02:59 am
immx
Medium
Report
3/3
08:53 am
immx
Immix Biopharma to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Medium
Report
Immix Biopharma to Participate in Upcoming Investor Conferences [Yahoo! Finance]
3/3
08:45 am
immx
Immix Biopharma to Participate in Upcoming Investor Conferences
Low
Report
Immix Biopharma to Participate in Upcoming Investor Conferences
2/14
01:32 am
immx
Immix Biopharma (NASDAQ:IMMX) was downgraded by analysts at
Wall Street
Medium
Report
Immix Biopharma (NASDAQ:IMMX) was downgraded by analysts at
Wall Street
2/10
07:02 am
immx
Immix Biopharma (NASDAQ:IMMX) was upgraded by analysts at Mizuho to a "strong-buy" rating.
Low
Report
Immix Biopharma (NASDAQ:IMMX) was upgraded by analysts at Mizuho to a "strong-buy" rating.
2/9
07:20 am
immx
Immix Biopharma (NASDAQ:IMMX) was given a new $14.00 price target on by analysts at Mizuho.
Medium
Report
Immix Biopharma (NASDAQ:IMMX) was given a new $14.00 price target on by analysts at Mizuho.
1/31
01:33 am
immx
Immix Biopharma (NASDAQ:IMMX) was upgraded by analysts at
Wall Street Ze
Medium
Report
Immix Biopharma (NASDAQ:IMMX) was upgraded by analysts at
Wall Street Ze
1/28
08:45 am
immx
Immix Biopharma Receives U.S. FDA Breakthrough Therapy Designation for NXC-201
Medium
Report
Immix Biopharma Receives U.S. FDA Breakthrough Therapy Designation for NXC-201
1/24
05:08 am
immx
Immix Biopharma (NASDAQ:IMMX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
Immix Biopharma (NASDAQ:IMMX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
1/10
01:07 am
immx
Immix Biopharma (NASDAQ:IMMX) was downgraded by analysts at
Wall Street
High
Report
Immix Biopharma (NASDAQ:IMMX) was downgraded by analysts at
Wall Street